Proteomics Market by Component (Instruments, Reagents, and Services) and Application (Drug Discovery, Disease Diagnosis, and Others): Global Opportunity Analysis and Industry Forecast, 2019-2027
The global proteomics market was valued at $21,122.32 million in 2019 and is projected to reach $49,978.80 million by 2027, registering a CAGR of 12.2% from 2020 to 2027. Proteomics is the study of the structure and functions of proteins. It is a complex study as compared to genomics, as genomes are constant, while proteomes differ depending on the cells and time.
The global proteomics market has witnessed significant growth over the past few years, owing to increased utility of proteomics in the diagnosis of diseases and identification of potential new drugs for the treatment of various diseases. Factors such as rise in focus of key players toward product development, surge in R&D expenditure on proteomics, increase in popularity for personalized medicines, and technological advancements in proteomics are expected to drive the market. However, stringent regulatory approvals, high cost of instruments, and dearth of qualified researchers are expected to hamper the market growth.
The global proteomics market is segmented on the basis of component, application, and region. On the basis of component, the market is categorized into reagents, instruments, and services. The reagents segment is further classified into microarray, spectrometry, X-ray crystallography, chromatography, electrophoresis, immunoassay, and protein fractionation reagents. Likewise, the proteomics instruments segment is sub segmented into protein microarray, spectrometry, chromatography, electrophoresis, surface plasmon resonance, X-ray crystallography, and protein fractionation systems. The spectrometry segment is subdivided into mass spectrometry and NMR spectrometry.
Likewise, the chromatography segment is sub classified into HPLC systems, ion chromatography, affinity chromatography, and supercritical fluid chromatography. The applications covered in the study include drug discovery, disease diagnosis, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key companies profiled in the report include Agilent Technologies Inc., Danaher Corporation, LI-COR, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., HORIBA, Ltd., Bio-Rad Laboratories, Inc., Bruker Corporation, General Electric (GE), and Waters Corporation. The other players included in the value chain analysis (but not included in the report) are Becton, Dickinson and Company, Caprion Biosciences, and others.
KEY BENEFITS FOR STAKEHOLDERS
By Component
The global proteomics market has witnessed significant growth over the past few years, owing to increased utility of proteomics in the diagnosis of diseases and identification of potential new drugs for the treatment of various diseases. Factors such as rise in focus of key players toward product development, surge in R&D expenditure on proteomics, increase in popularity for personalized medicines, and technological advancements in proteomics are expected to drive the market. However, stringent regulatory approvals, high cost of instruments, and dearth of qualified researchers are expected to hamper the market growth.
The global proteomics market is segmented on the basis of component, application, and region. On the basis of component, the market is categorized into reagents, instruments, and services. The reagents segment is further classified into microarray, spectrometry, X-ray crystallography, chromatography, electrophoresis, immunoassay, and protein fractionation reagents. Likewise, the proteomics instruments segment is sub segmented into protein microarray, spectrometry, chromatography, electrophoresis, surface plasmon resonance, X-ray crystallography, and protein fractionation systems. The spectrometry segment is subdivided into mass spectrometry and NMR spectrometry.
Likewise, the chromatography segment is sub classified into HPLC systems, ion chromatography, affinity chromatography, and supercritical fluid chromatography. The applications covered in the study include drug discovery, disease diagnosis, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key companies profiled in the report include Agilent Technologies Inc., Danaher Corporation, LI-COR, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., HORIBA, Ltd., Bio-Rad Laboratories, Inc., Bruker Corporation, General Electric (GE), and Waters Corporation. The other players included in the value chain analysis (but not included in the report) are Becton, Dickinson and Company, Caprion Biosciences, and others.
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the global proteomics market along with the current trends and future estimations to elucidate the imminent investment pockets.
- The report provides a quantitative analysis for the period of 2019–2027 to enable stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the market by components helps to understand the various types of instruments used across geographies.
- Comprehensive analysis of all geographic regions is provided to determine the prevailing opportunities in these regions.
- Key market players have been profiled in the report and their strategies have been analysed thoroughly to understand the competitive outlook of the global market.
- Extensive analysis of the market is conducted by closely following key product positioning and monitoring the top contenders within the market framework.
By Component
- Instruments
- Microarray
- Spectrometry
- Mass Spectrometry
- NMR Spectrometry
- X-ray Crystallography
- Chromatography
- HPLC Systems
- Ion Chromatography
- Affinity Chromatography
- Supercritical Fluid Chromatography
- Electrophoresis
- Surface Plasmon Resonance
- Protein Fractionation Reagents
- Reagents
- Microarray
- Spectroscopy
- X-ray Crystallography
- Chromatography
- Electrophoresis
- Immunoassay
- Protein Fractionation Reagents
- Services
- Drug Discovery
- Disease Diagnosis
- Others
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Australia
- Japan
- India
- China
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Agilent Technologies Inc.
- Bio-Rad Laboratories, Inc.
- Bruker Corporation
- Danaher Corporation
- General Electric (GE)
- HORIBA, Ltd.
- LI-COR, Inc.
- PerkinElmer, Inc.
- Waters Corporation
- Thermo Fisher Scientific, Inc.
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.1.1.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top winning strategies
3.2.2.Top investment pockets
3.2.3.Top player positioning
3.3.Porter’s five forces analysis
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Increase in popularity of personalized medicines
3.4.1.2.Increase in R&D expenditure
3.4.1.3.Technological advancements associated with proteomics components
3.4.2.Restraints
3.4.2.1.High costs associated with proteomics components
3.4.2.2.Dearth of skilled professionals
3.4.3.Opportunities
3.4.3.1.Lucrative opportunities associated with biomarker identification
3.4.3.2.Developments in mass spectrometry-based proteomics
3.5.COVID-19 impact analysis for proteomics market
CHAPTER 4:PROTEOMICS MARKET, BY COMPONENT
4.1.Overview
4.1.1.Market size and forecast
4.2.Reagents
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast
4.2.3.Market size and forecast, by component type
4.2.4.Microarray
4.2.4.1.Market size and forecast
4.2.5.Spectrometry
4.2.5.1.Market size and forecast
4.2.6.X-ray crystallography
4.2.6.1.Market size and forecast
4.2.7.Chromatography
4.2.7.1.Market size and forecast
4.2.8.Electrophoresis
4.2.8.1.Market size and forecast
4.2.9.Immunoassay
4.2.9.1.Market size and forecast
4.2.10.Protein fractionation reagents
4.2.10.1.Market size and forecast
4.2.11.Market analysis, by country
4.3.Instruments
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Microarray
4.3.3.1.Market size and forecast
4.3.4.Spectrometry
4.3.4.1.Market size and forecast
4.3.4.2.Market size and forecast
4.3.4.2.1.Mass spectrometry
4.3.4.2.1.1.Market size and forecast
4.3.4.2.2.NMR spectrometry
4.3.4.2.2.1.Market size and forecast
4.3.5.Chromatography
4.3.5.1.Market size and forecast
4.3.5.2.Market size and forecast
4.3.5.2.1.HPLC systems
4.3.5.2.1.1.Market size and forecast
4.3.5.2.2.Ion chromatography
4.3.5.2.2.1.Market size and forecast
4.3.5.2.3.Affinity chromatography
4.3.5.2.3.1.Market size and forecast
4.3.5.2.4.Supercritical fluid chromatography
4.3.5.2.4.1.Market size and forecast
4.3.6.Electrophoresis
4.3.6.1.Market size and forecast
4.3.7.Surface plasmon resonance
4.3.7.1.Market size and forecast
4.3.8.X-ray crystallography
4.3.8.1.Market size and forecast
4.3.9.Protein fractionation systems
4.3.9.1.Market size and forecast
4.3.10.Market analysis, by country
4.4.Services
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country
CHAPTER 5:PROTEOMICS MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Drug discovery
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Disease diagnosis
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.4.Others
5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country
CHAPTER 6:PROTEOMICS MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast
6.2.North America
6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by country
6.2.2.1.U.S.
6.2.2.1.1.U.S. proteomics market, by component
6.2.2.1.2.U.S. proteomics market, by application
6.2.2.2.Canada
6.2.2.2.1.Canada proteomics market, by component
6.2.2.2.2.Canada proteomics market, by application
6.2.2.3.Mexico
6.2.2.3.1.Mexico proteomics market, by component
6.2.2.3.2.Mexico proteomics market, by application
6.2.3.North America proteomics market, by component
6.2.4.North America proteomics market, by application
6.3.Europe
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by country
6.3.2.1.Germany
6.3.2.1.1.Germany proteomics market, by component
6.3.2.1.2.Germany proteomics market, by application
6.3.2.2.France
6.3.2.2.1.France proteomics market, by component
6.3.2.2.2.France proteomics market, by application
6.3.2.3.UK
6.3.2.3.1.UK proteomics market, by component
6.3.2.3.2.UK proteomics market, by application
6.3.2.4.Italy
6.3.2.4.1.Italy proteomics market, by component
6.3.2.4.2.Italy proteomics market, by application
6.3.2.5.Spain
6.3.2.5.1.Spain proteomics market, by component
6.3.2.5.2.Spain proteomics market, by application
6.3.2.6.Rest of Europe
6.3.2.6.1.Rest of Europe proteomics market, by component
6.3.2.6.2.Rest of Europe proteomics market, by application
6.3.3.Europe proteomics market, by component
6.3.4.Europe proteomics market, by application
6.4.Asia-Pacific
6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by country
6.4.2.1.Japan
6.4.2.1.1.Japan proteomics market, by component
6.4.2.1.2.Japan proteomics market, by application
6.4.2.2.China
6.4.2.2.1.China proteomics market, by component
6.4.2.2.2.China proteomics market, by application
6.4.2.3.India
6.4.2.3.1.India proteomics market, by component
6.4.2.3.2.India proteomics market, by application
6.4.2.4.Australia
6.4.2.4.1.Australia proteomics market, by component
6.4.2.4.2.Australia proteomics market, by application
6.4.2.5.South Korea
6.4.2.5.1.South Korea proteomics market, by component
6.4.2.5.2.South Korea proteomics market, by application
6.4.2.6.Rest of Asia-Pacific
6.4.2.6.1.Rest of Asia-Pacific proteomics market, by component
6.4.2.6.2.Rest of Asia-Pacific proteomics market, by application
6.4.3.Asia-Pacific proteomics market, by component
6.4.4.Asia-Pacific proteomics market, by application
6.5.LAMEA
6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast, by country
6.5.2.1.Brazil
6.5.2.1.1.Brazil proteomics market, by component
6.5.2.1.2.Brazil proteomics market, by application
6.5.2.2.Saudi Arabia
6.5.2.2.1.Saudi Arabia proteomics market, by component
6.5.2.2.2.Saudi Arabia proteomics market, by application
6.5.2.3.South Africa
6.5.2.3.1.South Africa proteomics market, by component
6.5.2.3.2.South Africa proteomics market, by application
6.5.2.4.Rest of LAMEA
6.5.2.4.1.Rest of LAMEA proteomics market, by component
6.5.2.4.2.Rest of LAMEA proteomics market, by application
6.5.3.LAMEA proteomics market, by component
6.5.4.LAMEA proteomics market, by application
CHAPTER 7:COMPANY PROFILES
7.1.AGILENT TECHNOLOGIES INC.
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance
7.1.6.Key strategic moves and developments
7.2.BIO-RAD LABORATORIES, INC.
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Business performance
7.2.6.Key strategic moves and developments
7.3.BRUKER CORPORATION
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product type portfolio
7.3.5.Business performance
7.3.6.Key strategic moves and developments
7.4.DANHER CORPORATION.
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance
7.4.6.Key strategic moves and developments
7.5.GE HEALTHCARE
7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product Portfolio
7.5.5.Business performance
7.6.HORIBA, LTD.
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance
7.7.LI-COR, INC.
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.8.PERKINELMER INC.
7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product Portfolio
7.8.5.Business performance
7.9.THERMO FISHER SCIENTIFIC, INC.
7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance
7.9.6.Key strategic moves and developments
7.10.WATERS CORPORATION
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product type portfolio
7.10.5.Business performance
7.10.6.Key strategic moves and developments
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.1.1.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top winning strategies
3.2.2.Top investment pockets
3.2.3.Top player positioning
3.3.Porter’s five forces analysis
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Increase in popularity of personalized medicines
3.4.1.2.Increase in R&D expenditure
3.4.1.3.Technological advancements associated with proteomics components
3.4.2.Restraints
3.4.2.1.High costs associated with proteomics components
3.4.2.2.Dearth of skilled professionals
3.4.3.Opportunities
3.4.3.1.Lucrative opportunities associated with biomarker identification
3.4.3.2.Developments in mass spectrometry-based proteomics
3.5.COVID-19 impact analysis for proteomics market
CHAPTER 4:PROTEOMICS MARKET, BY COMPONENT
4.1.Overview
4.1.1.Market size and forecast
4.2.Reagents
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast
4.2.3.Market size and forecast, by component type
4.2.4.Microarray
4.2.4.1.Market size and forecast
4.2.5.Spectrometry
4.2.5.1.Market size and forecast
4.2.6.X-ray crystallography
4.2.6.1.Market size and forecast
4.2.7.Chromatography
4.2.7.1.Market size and forecast
4.2.8.Electrophoresis
4.2.8.1.Market size and forecast
4.2.9.Immunoassay
4.2.9.1.Market size and forecast
4.2.10.Protein fractionation reagents
4.2.10.1.Market size and forecast
4.2.11.Market analysis, by country
4.3.Instruments
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Microarray
4.3.3.1.Market size and forecast
4.3.4.Spectrometry
4.3.4.1.Market size and forecast
4.3.4.2.Market size and forecast
4.3.4.2.1.Mass spectrometry
4.3.4.2.1.1.Market size and forecast
4.3.4.2.2.NMR spectrometry
4.3.4.2.2.1.Market size and forecast
4.3.5.Chromatography
4.3.5.1.Market size and forecast
4.3.5.2.Market size and forecast
4.3.5.2.1.HPLC systems
4.3.5.2.1.1.Market size and forecast
4.3.5.2.2.Ion chromatography
4.3.5.2.2.1.Market size and forecast
4.3.5.2.3.Affinity chromatography
4.3.5.2.3.1.Market size and forecast
4.3.5.2.4.Supercritical fluid chromatography
4.3.5.2.4.1.Market size and forecast
4.3.6.Electrophoresis
4.3.6.1.Market size and forecast
4.3.7.Surface plasmon resonance
4.3.7.1.Market size and forecast
4.3.8.X-ray crystallography
4.3.8.1.Market size and forecast
4.3.9.Protein fractionation systems
4.3.9.1.Market size and forecast
4.3.10.Market analysis, by country
4.4.Services
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country
CHAPTER 5:PROTEOMICS MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Drug discovery
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Disease diagnosis
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.4.Others
5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country
CHAPTER 6:PROTEOMICS MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast
6.2.North America
6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by country
6.2.2.1.U.S.
6.2.2.1.1.U.S. proteomics market, by component
6.2.2.1.2.U.S. proteomics market, by application
6.2.2.2.Canada
6.2.2.2.1.Canada proteomics market, by component
6.2.2.2.2.Canada proteomics market, by application
6.2.2.3.Mexico
6.2.2.3.1.Mexico proteomics market, by component
6.2.2.3.2.Mexico proteomics market, by application
6.2.3.North America proteomics market, by component
6.2.4.North America proteomics market, by application
6.3.Europe
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by country
6.3.2.1.Germany
6.3.2.1.1.Germany proteomics market, by component
6.3.2.1.2.Germany proteomics market, by application
6.3.2.2.France
6.3.2.2.1.France proteomics market, by component
6.3.2.2.2.France proteomics market, by application
6.3.2.3.UK
6.3.2.3.1.UK proteomics market, by component
6.3.2.3.2.UK proteomics market, by application
6.3.2.4.Italy
6.3.2.4.1.Italy proteomics market, by component
6.3.2.4.2.Italy proteomics market, by application
6.3.2.5.Spain
6.3.2.5.1.Spain proteomics market, by component
6.3.2.5.2.Spain proteomics market, by application
6.3.2.6.Rest of Europe
6.3.2.6.1.Rest of Europe proteomics market, by component
6.3.2.6.2.Rest of Europe proteomics market, by application
6.3.3.Europe proteomics market, by component
6.3.4.Europe proteomics market, by application
6.4.Asia-Pacific
6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by country
6.4.2.1.Japan
6.4.2.1.1.Japan proteomics market, by component
6.4.2.1.2.Japan proteomics market, by application
6.4.2.2.China
6.4.2.2.1.China proteomics market, by component
6.4.2.2.2.China proteomics market, by application
6.4.2.3.India
6.4.2.3.1.India proteomics market, by component
6.4.2.3.2.India proteomics market, by application
6.4.2.4.Australia
6.4.2.4.1.Australia proteomics market, by component
6.4.2.4.2.Australia proteomics market, by application
6.4.2.5.South Korea
6.4.2.5.1.South Korea proteomics market, by component
6.4.2.5.2.South Korea proteomics market, by application
6.4.2.6.Rest of Asia-Pacific
6.4.2.6.1.Rest of Asia-Pacific proteomics market, by component
6.4.2.6.2.Rest of Asia-Pacific proteomics market, by application
6.4.3.Asia-Pacific proteomics market, by component
6.4.4.Asia-Pacific proteomics market, by application
6.5.LAMEA
6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast, by country
6.5.2.1.Brazil
6.5.2.1.1.Brazil proteomics market, by component
6.5.2.1.2.Brazil proteomics market, by application
6.5.2.2.Saudi Arabia
6.5.2.2.1.Saudi Arabia proteomics market, by component
6.5.2.2.2.Saudi Arabia proteomics market, by application
6.5.2.3.South Africa
6.5.2.3.1.South Africa proteomics market, by component
6.5.2.3.2.South Africa proteomics market, by application
6.5.2.4.Rest of LAMEA
6.5.2.4.1.Rest of LAMEA proteomics market, by component
6.5.2.4.2.Rest of LAMEA proteomics market, by application
6.5.3.LAMEA proteomics market, by component
6.5.4.LAMEA proteomics market, by application
CHAPTER 7:COMPANY PROFILES
7.1.AGILENT TECHNOLOGIES INC.
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance
7.1.6.Key strategic moves and developments
7.2.BIO-RAD LABORATORIES, INC.
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Business performance
7.2.6.Key strategic moves and developments
7.3.BRUKER CORPORATION
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product type portfolio
7.3.5.Business performance
7.3.6.Key strategic moves and developments
7.4.DANHER CORPORATION.
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance
7.4.6.Key strategic moves and developments
7.5.GE HEALTHCARE
7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product Portfolio
7.5.5.Business performance
7.6.HORIBA, LTD.
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance
7.7.LI-COR, INC.
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.8.PERKINELMER INC.
7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product Portfolio
7.8.5.Business performance
7.9.THERMO FISHER SCIENTIFIC, INC.
7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance
7.9.6.Key strategic moves and developments
7.10.WATERS CORPORATION
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product type portfolio
7.10.5.Business performance
7.10.6.Key strategic moves and developments
LIST OF TABLES
TABLE 01.GLOBAL PROTEOMICS REAGENTS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 02.PROTEOMICS REAGENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 03.PROTEOMICS REAGENTS MARKET, BY COMPONENT TYPE, 2019–2027 ($MILLION)
TABLE 04.PROTEOMICS INSTRUMENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 05.PROTEOMICS INSTRUMENTS MARKET, BY COMPONENT TYPE, 2019–2027 ($MILLION)
TABLE 06.PROTEOMICS INSTRUMENTS MARKET FOR SPECTROMETRY, BY TYPE, 2019–2027 ($MILLION)
TABLE 07.PROTEOMICS INSTRUMENTS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2019–2027 ($MILLION)
TABLE 08.PROTEOMICS SERVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 09.PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 10.PROTEOMICS MARKET FOR DRUG DISCOVERY, BY REGION, 2019–2027 ($MILLION)
TABLE 11.PROTEOMICS MARKET FOR DISEASE DIAGNOSIS, BY REGION, 2019–2027 ($MILLION)
TABLE 12.PROTEOMICS MARKET FOR OTHERS, BY REGION, 2019–2027 ($MILLION)
TABLE 01.PROTEOMICS MARKET REVENUE, BY REGION, 2019–2027 ($MILLION)
TABLE 02.NORTH AMERICA PROTEOMICS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 03.U.S. PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 04.U.S. PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 05.CANADA PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 06.CANADA PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 07.MEXICO PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 08.MEXICO PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 09.NORTH AMERICA PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 10.NORTH AMERICA PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 11.EUROPE PROTEOMICS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 12.GERMANY PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 13.GERMANY PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 14.FRANCE PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 15.FRANCE PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 16.UK PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 17.UK PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 18.ITALY PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 19.ITALY PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 20.SPAIN PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 21.SPAIN PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 22.REST OF EUROPE PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 23.REST OF EUROPE PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 24.EUROPE PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 25.EUROPE PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 26.ASIA-PACIFIC PROTEOMICS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 27.JAPAN PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 28.JAPAN PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 29.CHINA PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 30.CHINA PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 31.INDIA PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 32.INDIA PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 33.AUSTRALIA PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 34.AUSTRALIA PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 35.SOUTH KOREA PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 36.SOUTH KOREA PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 37.REST OF ASIA-PACIFIC PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 38.REST OF ASIA-PACIFIC PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 39.ASIA-PACIFIC PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 40.ASIA-PACIFIC PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 41.LAMEA PROTEOMICS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 42.BRAZIL PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 43.BRAZIL PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 44.SAUDI ARABIA PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 45.SAUDI ARABIA PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 46.SOUTH AFRICA PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 47.SOUTH AFRICA PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 48.REST OF LAMEA PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 49.REST OF LAMEA PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 50.LAMEA PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 51.LAMEA PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 52.AGILENT: COMPANY SNAPSHOT
TABLE 53.AGILENT: OPERATING SEGMENTS
TABLE 54.AGILENT: PRODUCT PORTFOLIO
TABLE 55.BIO-RAD: COMPANY SNAPSHOT
TABLE 56.BIO-RAD: OERATING SEGMENT
TABLE 57.BIO-RAD: PRODUCT PORTFOLIO
TABLE 58.BRUKER: COMPANY SNAPSHOT
TABLE 59.BRUKER: OPERATING SEGMENTS
TABLE 60.BRUKER: PRODUCT TYPE PORTFOLIO
TABLE 61.DANAHER: COMPANY SNAPSHOT
TABLE 62.DANAHER: OPERATING SEGMENTS
TABLE 63.DANAHER: PRODUCT PORTFOLIO
TABLE 64.GE HEALTHCARE: COMPANY SNAPSHOT
TABLE 65.GE HEALTHCARE: OPERATING SEGMENTS
TABLE 66.GE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 67.HORIBA: COMPANY SNAPSHOT
TABLE 68.HORIBA: BUSINESS SEGMENTS
TABLE 69.HORIBA: PRODUCT PORTFOLIO
TABLE 70.LI-COR, INC.: COMPANY SNAPSHOT
TABLE 71.LI-COR, INC.: OPERATING SEGMENTS
TABLE 72.LI-COR, INC.: PRODUCT PORTFOLIO
TABLE 73.PERKINELMER: COMPANY SNAPSHOT
TABLE 74.PERKINELMER: OPERATING SEGMENTS
TABLE 75.PERKINELMER: PRODUCT PORTFOLIO
TABLE 76.THERMO FISHER SCIENTIFIC.: COMPANY SNAPSHOT
TABLE 77.THERMO FISHER SCIENTIFIC: PRODUCT SEGMENTS
TABLE 78.THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 79.WATERS: COMPANY SNAPSHOT
TABLE 80.WATERS: OPERATING SEGMENTS
TABLE 81.WATERS: PRODUCT PORTFOLIO
TABLE 01.GLOBAL PROTEOMICS REAGENTS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 02.PROTEOMICS REAGENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 03.PROTEOMICS REAGENTS MARKET, BY COMPONENT TYPE, 2019–2027 ($MILLION)
TABLE 04.PROTEOMICS INSTRUMENTS MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 05.PROTEOMICS INSTRUMENTS MARKET, BY COMPONENT TYPE, 2019–2027 ($MILLION)
TABLE 06.PROTEOMICS INSTRUMENTS MARKET FOR SPECTROMETRY, BY TYPE, 2019–2027 ($MILLION)
TABLE 07.PROTEOMICS INSTRUMENTS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2019–2027 ($MILLION)
TABLE 08.PROTEOMICS SERVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 09.PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 10.PROTEOMICS MARKET FOR DRUG DISCOVERY, BY REGION, 2019–2027 ($MILLION)
TABLE 11.PROTEOMICS MARKET FOR DISEASE DIAGNOSIS, BY REGION, 2019–2027 ($MILLION)
TABLE 12.PROTEOMICS MARKET FOR OTHERS, BY REGION, 2019–2027 ($MILLION)
TABLE 01.PROTEOMICS MARKET REVENUE, BY REGION, 2019–2027 ($MILLION)
TABLE 02.NORTH AMERICA PROTEOMICS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 03.U.S. PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 04.U.S. PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 05.CANADA PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 06.CANADA PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 07.MEXICO PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 08.MEXICO PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 09.NORTH AMERICA PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 10.NORTH AMERICA PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 11.EUROPE PROTEOMICS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 12.GERMANY PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 13.GERMANY PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 14.FRANCE PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 15.FRANCE PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 16.UK PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 17.UK PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 18.ITALY PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 19.ITALY PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 20.SPAIN PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 21.SPAIN PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 22.REST OF EUROPE PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 23.REST OF EUROPE PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 24.EUROPE PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 25.EUROPE PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 26.ASIA-PACIFIC PROTEOMICS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 27.JAPAN PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 28.JAPAN PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 29.CHINA PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 30.CHINA PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 31.INDIA PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 32.INDIA PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 33.AUSTRALIA PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 34.AUSTRALIA PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 35.SOUTH KOREA PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 36.SOUTH KOREA PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 37.REST OF ASIA-PACIFIC PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 38.REST OF ASIA-PACIFIC PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 39.ASIA-PACIFIC PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 40.ASIA-PACIFIC PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 41.LAMEA PROTEOMICS MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 42.BRAZIL PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 43.BRAZIL PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 44.SAUDI ARABIA PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 45.SAUDI ARABIA PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 46.SOUTH AFRICA PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 47.SOUTH AFRICA PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 48.REST OF LAMEA PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 49.REST OF LAMEA PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 50.LAMEA PROTEOMICS MARKET, BY COMPONENT, 2019–2027 ($MILLION)
TABLE 51.LAMEA PROTEOMICS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 52.AGILENT: COMPANY SNAPSHOT
TABLE 53.AGILENT: OPERATING SEGMENTS
TABLE 54.AGILENT: PRODUCT PORTFOLIO
TABLE 55.BIO-RAD: COMPANY SNAPSHOT
TABLE 56.BIO-RAD: OERATING SEGMENT
TABLE 57.BIO-RAD: PRODUCT PORTFOLIO
TABLE 58.BRUKER: COMPANY SNAPSHOT
TABLE 59.BRUKER: OPERATING SEGMENTS
TABLE 60.BRUKER: PRODUCT TYPE PORTFOLIO
TABLE 61.DANAHER: COMPANY SNAPSHOT
TABLE 62.DANAHER: OPERATING SEGMENTS
TABLE 63.DANAHER: PRODUCT PORTFOLIO
TABLE 64.GE HEALTHCARE: COMPANY SNAPSHOT
TABLE 65.GE HEALTHCARE: OPERATING SEGMENTS
TABLE 66.GE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 67.HORIBA: COMPANY SNAPSHOT
TABLE 68.HORIBA: BUSINESS SEGMENTS
TABLE 69.HORIBA: PRODUCT PORTFOLIO
TABLE 70.LI-COR, INC.: COMPANY SNAPSHOT
TABLE 71.LI-COR, INC.: OPERATING SEGMENTS
TABLE 72.LI-COR, INC.: PRODUCT PORTFOLIO
TABLE 73.PERKINELMER: COMPANY SNAPSHOT
TABLE 74.PERKINELMER: OPERATING SEGMENTS
TABLE 75.PERKINELMER: PRODUCT PORTFOLIO
TABLE 76.THERMO FISHER SCIENTIFIC.: COMPANY SNAPSHOT
TABLE 77.THERMO FISHER SCIENTIFIC: PRODUCT SEGMENTS
TABLE 78.THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 79.WATERS: COMPANY SNAPSHOT
TABLE 80.WATERS: OPERATING SEGMENTS
TABLE 81.WATERS: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.GLOBAL PROTEOMICS MARKET SEGMENTATION
FIGURE 02.TOP WINNING STRATEGIES, 2017–2020
FIGURE 03.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017–2020
FIGURE 04.TOP WINNING STRATEGIES, BY COMPANY, 2017–2020
FIGURE 05.TOP INVESTMENT POCKETS
FIGURE 06.TOP PLAYER POSITIONING, 2019
FIGURE 07.HIGH BARGAINING POWER OF BUYERS
FIGURE 08.HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 09.MODERATE THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE THREAT OF SUBSTITUTION
FIGURE 11.HIGH COMPETITIVE RIVALRY
FIGURE 12.DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 13.PROTEOMICS REAGENTS MARKET FOR MICROARRAY, 2019–2027 ($MILLION)
FIGURE 14.PROTEOMICS REAGENTS MARKET FOR SPECTROMETRY, 2019–2027 ($MILLION)
FIGURE 15.PROTEOMICS REAGENTS MARKET FOR X-RAY CRYSTALLOGRAPHY, 2019–2027 ($MILLION)
FIGURE 16.PROTEOMICS REAGENTS MARKET FOR CHROMATOGRAPHY, 2019–2027 ($MILLION)
FIGURE 17.PROTEOMICS REAGENTS MARKET FOR ELECTROPHORESIS, 2019–2027 ($MILLION)
FIGURE 18.PROTEOMICS REAGENTS MARKET FOR IMMUNOASSAY, 2019–2027 ($MILLION)
FIGURE 19.PROTEOMICS REAGENTS MARKET FOR PROTEIN FRACTIONATION REAGENTS, 2019–2027 ($MILLION)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF PROTEOMICS REAGENTS MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 21.PROTEOMICS INSTRUMENTS MARKET FOR MICROARRAY, 2019–2027 ($MILLION)
FIGURE 22.PROTEOMICS INSTRUMENTS MARKET FOR SPECTROMETRY, 2019–2027 ($MILLION)
FIGURE 23.PROTEOMICS INSTRUMENTS MARKET FOR MASS SPECTROMETRY, 2019–2027 ($MILLION)
FIGURE 24.NMR SPECTROMETRY PROTEOMICS INSTRUMENTS MARKET, 2019–2027 ($MILLION)
FIGURE 25.PROTEOMICS INSTRUMENTS MARKET FOR CHROMATOGRAPHY, 2019–2027 ($MILLION)
FIGURE 26.PROTEOMICS INSTRUMENTS MARKET FOR HPLC SYSTEMS, 2019–2027 ($MILLION)
FIGURE 27.PROTEOMICS INSTRUMENTS MARKET FOR ION CHROMATOGRAPHY, 2019–2027 ($MILLION)
FIGURE 28.PROTEOMICS INSTRUMENTS MARKET FOR AFFINITY CHROMATOGRAPHY, 2019–2027 ($MILLION)
FIGURE 29.PROTEOMICS INSTRUMENTS MARKET FOR SUPERFICIAL FLUID CHROMATOGRAPHY, 2019–2027 ($MILLION)
FIGURE 30.PROTEOMICS INSTRUMENTS MARKET FOR ELECTROPHORESIS, 2019–2027 ($MILLION)
FIGURE 31.PROTEOMICS INSTRUMENTS MARKET FOR SURFACE PLASMON RESONANCE, 2019–2027 ($MILLION)
FIGURE 32.PROTEOMICS INSTRUMENTS MARKET FOR X-RAY CRYSTALLOGRAPHY, 2019–2027 ($MILLION)
FIGURE 33.PROTEOMICS INSTRUMENTS MARKET FOR PROTEIN FRACTIONATION SYSTEMS, 2019–2027 ($MILLION)
FIGURE 34.COMPARATIVE SHARE ANALYSIS OF PROTEOMICS INSTRUMENTS MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 35.COMPARATIVE SHARE ANALYSIS OF PROTEOMICS SERVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 36.COMPARATIVE ANALYSIS OF PROTEOMICS MARKET, FOR DRUG DISCOVERY BY COUNTRY, 2019–2027 (%)
FIGURE 37.COMPARATIVE ANALYSIS OF PROTEOMICS MARKET, FOR DISEASE DIAGNOSIS BY COUNTRY, 2019–2027 (%)
FIGURE 38.COMPARATIVE ANALYSIS OF PROTEOMICS MARKET, FOR OTHERS BY COUNTRY, 2019–2027 (%)
FIGURE 39.AGILENT: NET SALES, 2017–2019 ($MILLION)
FIGURE 40.AGILENT: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 41.AGILENT: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 42.BIO-RAD: NET SALES, 2017–2019 ($MILLION)
FIGURE 43.BIO-RAD: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 44.BIO-RAD: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 45.BRUKER: NET SALES, 2017–2019 ($MILLION)
FIGURE 46.BRUKER: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 47.BRUKER: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 48.DANAHER: NET SALES, 2017–2019 ($MILLION)
FIGURE 49.DANAHER: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 50.DANAHER: REVENUE SHARE BY GEOGRAPHY, 2019 (%)
FIGURE 51.GE HEALTHCARE: NET SALES, 2017–2019 ($MILLION)
FIGURE 52.GE HEALTHCARE: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 53.GE HEALTHCARE: REVENUE SHARE BY REGION, 2019(%)
FIGURE 54.HORIBA: NET SALES, 2017–2019 ($MILLION)
FIGURE 55.HORIBA: NET SALES, BY SEGMENT, 2019 (%)
FIGURE 56.HORIBA: NET SALES, BY REGION, 2019 (%)
FIGURE 57.PERKINELMER: NET SALES, 2015–2017 ($MILLION)
FIGURE 58.PERKINELMER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 59.PERKINELMER: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 60.THERMO FISHER SCIENTIFIC, INC.: NET SALES, 2017–2019 ($MILLION)
FIGURE 61.THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE BY SEGMENTS, 2019 (%)
FIGURE 62.THERMO FISHER SCIENTIFIC. REVENUE SHARE BY REGION, 2019 (%)
FIGURE 63.WATERS: NET SALES, 2017–2019 ($MILLION)
FIGURE 64.WATERS: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 65.WATERS: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 01.GLOBAL PROTEOMICS MARKET SEGMENTATION
FIGURE 02.TOP WINNING STRATEGIES, 2017–2020
FIGURE 03.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017–2020
FIGURE 04.TOP WINNING STRATEGIES, BY COMPANY, 2017–2020
FIGURE 05.TOP INVESTMENT POCKETS
FIGURE 06.TOP PLAYER POSITIONING, 2019
FIGURE 07.HIGH BARGAINING POWER OF BUYERS
FIGURE 08.HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 09.MODERATE THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE THREAT OF SUBSTITUTION
FIGURE 11.HIGH COMPETITIVE RIVALRY
FIGURE 12.DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 13.PROTEOMICS REAGENTS MARKET FOR MICROARRAY, 2019–2027 ($MILLION)
FIGURE 14.PROTEOMICS REAGENTS MARKET FOR SPECTROMETRY, 2019–2027 ($MILLION)
FIGURE 15.PROTEOMICS REAGENTS MARKET FOR X-RAY CRYSTALLOGRAPHY, 2019–2027 ($MILLION)
FIGURE 16.PROTEOMICS REAGENTS MARKET FOR CHROMATOGRAPHY, 2019–2027 ($MILLION)
FIGURE 17.PROTEOMICS REAGENTS MARKET FOR ELECTROPHORESIS, 2019–2027 ($MILLION)
FIGURE 18.PROTEOMICS REAGENTS MARKET FOR IMMUNOASSAY, 2019–2027 ($MILLION)
FIGURE 19.PROTEOMICS REAGENTS MARKET FOR PROTEIN FRACTIONATION REAGENTS, 2019–2027 ($MILLION)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF PROTEOMICS REAGENTS MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 21.PROTEOMICS INSTRUMENTS MARKET FOR MICROARRAY, 2019–2027 ($MILLION)
FIGURE 22.PROTEOMICS INSTRUMENTS MARKET FOR SPECTROMETRY, 2019–2027 ($MILLION)
FIGURE 23.PROTEOMICS INSTRUMENTS MARKET FOR MASS SPECTROMETRY, 2019–2027 ($MILLION)
FIGURE 24.NMR SPECTROMETRY PROTEOMICS INSTRUMENTS MARKET, 2019–2027 ($MILLION)
FIGURE 25.PROTEOMICS INSTRUMENTS MARKET FOR CHROMATOGRAPHY, 2019–2027 ($MILLION)
FIGURE 26.PROTEOMICS INSTRUMENTS MARKET FOR HPLC SYSTEMS, 2019–2027 ($MILLION)
FIGURE 27.PROTEOMICS INSTRUMENTS MARKET FOR ION CHROMATOGRAPHY, 2019–2027 ($MILLION)
FIGURE 28.PROTEOMICS INSTRUMENTS MARKET FOR AFFINITY CHROMATOGRAPHY, 2019–2027 ($MILLION)
FIGURE 29.PROTEOMICS INSTRUMENTS MARKET FOR SUPERFICIAL FLUID CHROMATOGRAPHY, 2019–2027 ($MILLION)
FIGURE 30.PROTEOMICS INSTRUMENTS MARKET FOR ELECTROPHORESIS, 2019–2027 ($MILLION)
FIGURE 31.PROTEOMICS INSTRUMENTS MARKET FOR SURFACE PLASMON RESONANCE, 2019–2027 ($MILLION)
FIGURE 32.PROTEOMICS INSTRUMENTS MARKET FOR X-RAY CRYSTALLOGRAPHY, 2019–2027 ($MILLION)
FIGURE 33.PROTEOMICS INSTRUMENTS MARKET FOR PROTEIN FRACTIONATION SYSTEMS, 2019–2027 ($MILLION)
FIGURE 34.COMPARATIVE SHARE ANALYSIS OF PROTEOMICS INSTRUMENTS MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 35.COMPARATIVE SHARE ANALYSIS OF PROTEOMICS SERVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 36.COMPARATIVE ANALYSIS OF PROTEOMICS MARKET, FOR DRUG DISCOVERY BY COUNTRY, 2019–2027 (%)
FIGURE 37.COMPARATIVE ANALYSIS OF PROTEOMICS MARKET, FOR DISEASE DIAGNOSIS BY COUNTRY, 2019–2027 (%)
FIGURE 38.COMPARATIVE ANALYSIS OF PROTEOMICS MARKET, FOR OTHERS BY COUNTRY, 2019–2027 (%)
FIGURE 39.AGILENT: NET SALES, 2017–2019 ($MILLION)
FIGURE 40.AGILENT: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 41.AGILENT: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 42.BIO-RAD: NET SALES, 2017–2019 ($MILLION)
FIGURE 43.BIO-RAD: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 44.BIO-RAD: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 45.BRUKER: NET SALES, 2017–2019 ($MILLION)
FIGURE 46.BRUKER: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 47.BRUKER: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 48.DANAHER: NET SALES, 2017–2019 ($MILLION)
FIGURE 49.DANAHER: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 50.DANAHER: REVENUE SHARE BY GEOGRAPHY, 2019 (%)
FIGURE 51.GE HEALTHCARE: NET SALES, 2017–2019 ($MILLION)
FIGURE 52.GE HEALTHCARE: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 53.GE HEALTHCARE: REVENUE SHARE BY REGION, 2019(%)
FIGURE 54.HORIBA: NET SALES, 2017–2019 ($MILLION)
FIGURE 55.HORIBA: NET SALES, BY SEGMENT, 2019 (%)
FIGURE 56.HORIBA: NET SALES, BY REGION, 2019 (%)
FIGURE 57.PERKINELMER: NET SALES, 2015–2017 ($MILLION)
FIGURE 58.PERKINELMER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 59.PERKINELMER: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 60.THERMO FISHER SCIENTIFIC, INC.: NET SALES, 2017–2019 ($MILLION)
FIGURE 61.THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE BY SEGMENTS, 2019 (%)
FIGURE 62.THERMO FISHER SCIENTIFIC. REVENUE SHARE BY REGION, 2019 (%)
FIGURE 63.WATERS: NET SALES, 2017–2019 ($MILLION)
FIGURE 64.WATERS: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 65.WATERS: REVENUE SHARE BY REGION, 2019 (%)
